Myriad Genetics to Participate in Upcoming Investor Healthcare Conferences

Wells Fargo Healthcare Conference

09/04/2025 | 3:45pm EDT
Webcast Link

Morgan Stanley Annual Global Healthcare Conference

09/10/2025 | 7:45am EDT
Webcast Link

Events & Presentations

View all events

Financial Reports and Filings

Date Filing Title Downloads
09/04/2025 4 Statement of changes in beneficial ownership of securities RTF XLS PDF HTML XBRL
08/19/2025 4 Statement of changes in beneficial ownership of securities RTF XLS PDF HTML XBRL
08/19/2025 3 Initial filing by director officer or owner of more than ten percent RTF XLS PDF HTML XBRL
08/18/2025 4 Statement of changes in beneficial ownership of securities RTF XLS PDF HTML XBRL
08/18/2025 8-K Report of unscheduled material events or corporate event RTF XLS PDF HTML XBRL
08/14/2025 SCHEDULE 13G/A SCHEDULE 13G/A - Description RTF XLS PDF HTML XBRL
08/12/2025 SCHEDULE 13G SCHEDULE 13G - Description RTF XLS PDF HTML XBRL
08/12/2025 SCHEDULE 13G/A SCHEDULE 13G/A - Description RTF XLS PDF HTML XBRL
08/06/2025 10-Q Quarterly report which provides a continuing view of a company's financial position RTF XLS PDF HTML XBRL
08/05/2025 8-K Report of unscheduled material events or corporate event RTF XLS PDF HTML XBRL
View all filings

Latest News

Myriad Genetics Announces Precise MRD Clinical Data Published in The Lancet Oncology Thumbnail

Myriad Genetics Announces Precise MRD Clinical Data Published in The Lancet Oncology

Sep 04, 2025 | Products

Read more
New Meta-Analysis Demonstrates that Access to the GeneSight Test Can Significantly Improve Response and Remission Rates for Patients with Depression Thumbnail

New Meta-Analysis Demonstrates that Access to the GeneSight Test Can Significantly Improve Response and Remission Rates for Patients with Depression

Sep 03, 2025 | Products

Read more
Myriad Genetics to Participate in Upcoming Investor Healthcare Conferences Thumbnail

Myriad Genetics to Participate in Upcoming Investor Healthcare Conferences

Aug 27, 2025 | Corporate

Read more
View all news releases

Quality, Innovation and Corporate Responsibility Report

Myriad Genetics has a strong commitment to operational excellence, innovation and being a good corporate partner. Our dedication to these important issues serve as the foundation to achieving our mission of advancing health and well-being for all.

Learn more about the actions we’re taking in quality, innovation, and corporate responsibility.

Read our QICR report

Quality, Innovation and Corporate Responsibility Report

Myriad Genetics has a strong commitment to operational excellence, innovation and being a good corporate partner. Our dedication to these important issues serve as the foundation to achieving our mission of advancing health and well-being for all.

Learn more about the actions we’re taking in quality, innovation, and corporate responsibility.

Read our QICR report